Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$19,633 Mln
P/E Ratio
21.97
P/B Ratio
2.8
Industry P/E
50.24
Debt to Equity
0.85
ROE
0.14 %
ROCE
6.83 %
Div. Yield
1.84 %
Book Value
--
EPS
7.96
CFO
$13,663.00 Mln
EBITDA
$17,322.00 Mln
Net Profit
$9,502.00 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Quest Diagnostics (DGX)
| 17.12 | 6.43 | 10.45 | 31.60 | 8.72 | 8.78 | 9.02 |
|
BSE Sensex*
| 2.73 | 3.84 | 5.91 | 9.03 | 11.80 | 20.14 | 11.37 |
|
S&P Midcap 400
| -8.80 | -4.26 | -12.25 | -1.81 | 4.06 | 11.99 | 6.45 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Quest Diagnostics (DGX)
| 9.33 | -11.86 | -9.58 | 47.86 | 14.11 | 31.13 | -13.77 |
|
S&P Midcap 400
| 12.12 | 14.45 | -14.48 | 23.21 | 11.81 | 24.05 | -12.43 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 94.69 | 3,101.45 | 34.87 | 10.13 | |
| 565.86 | 8,121.97 | 27.1 | 27.8 | |
| 2.63 | 404.08 | -- | -- | |
| 115.32 | 11,417.38 | 23.33 | 15.7 |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic... pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Address: 500 Plaza Drive, Secaucus, NJ, United States, 07094 Read more
Chairman, CEO & President
Mr. James E. Davis
Executive VP & CFO
Mr. Sam A. Samad
Headquarters
Secaucus, NJ
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Quest Diagnostics Incorporated (DGX) stood at $ 17,238 Mln as on 31-Mar-25
The share price of Quest Diagnostics Incorporated (DGX) is $176.68 (NYSE) as of 28-Apr-2025 16:10 EDT. Quest Diagnostics Incorporated (DGX) has given a return of 8.72% in the last 3 years.
Quest Diagnostics Incorporated (DGX) has a market capitalisation of $ 19,633 Mln as on 28-Apr-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Quest Diagnostics Incorporated (DGX) is 2.80 times as on 28-Apr-2025, a 8% premium to its peers’ median range of 2.59 times.
The P/E ratio of Quest Diagnostics Incorporated (DGX) is 21.97 times as on 28-Apr-2025, a 56% discount to its peers’ median range of 50.24 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Quest Diagnostics Incorporated (DGX) and enter the required number of quantities and click on buy to purchase the shares of Quest Diagnostics Incorporated (DGX).
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Address: 500 Plaza Drive, Secaucus, NJ, United States, 07094
The CEO & director of Mr. James E. Davis. is Quest Diagnostics Incorporated (DGX), and CFO & Sr. VP is Mr. Sam A. Samad.
There is no promoter pledging in Quest Diagnostics Incorporated (DGX).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,014
|
|
|
856
|
|
|
307
|
|
|
34
|
| Quest Diagnostics Incorporated (DGX) | Ratios |
|---|---|
|
Return on equity(%)
|
12.32
|
|
Operating margin(%)
|
12.76
|
|
Net Margin(%)
|
8.83
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Quest Diagnostics Incorporated (DGX) was $0 Mln.
$2.92
(
